CN105477361B - 一种治疗胃炎的中药组合物制备方法及制剂 - Google Patents
一种治疗胃炎的中药组合物制备方法及制剂 Download PDFInfo
- Publication number
- CN105477361B CN105477361B CN201510939828.8A CN201510939828A CN105477361B CN 105477361 B CN105477361 B CN 105477361B CN 201510939828 A CN201510939828 A CN 201510939828A CN 105477361 B CN105477361 B CN 105477361B
- Authority
- CN
- China
- Prior art keywords
- preparation
- powder
- chinese medicine
- medicine composition
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 34
- 239000000284 extract Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 241000218176 Corydalis Species 0.000 claims abstract description 10
- 241000234435 Lilium Species 0.000 claims abstract description 10
- 241000209495 Acorus Species 0.000 claims abstract description 9
- 239000013543 active substance Substances 0.000 claims abstract description 9
- 239000012530 fluid Substances 0.000 claims abstract description 9
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims abstract description 6
- 235000019634 flavors Nutrition 0.000 claims abstract description 6
- 238000009472 formulation Methods 0.000 claims abstract description 5
- 239000006187 pill Substances 0.000 claims description 13
- 241000233948 Typha Species 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 5
- -1 is pelletized Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000009232 moluodan Substances 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 4
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 244000197580 Poria cocos Species 0.000 description 3
- 235000008599 Poria cocos Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 244000144993 groups of animals Species 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 210000001187 pylorus Anatomy 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 235000008671 Calycanthus floridus Nutrition 0.000 description 2
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 244000148992 Lindera benzoin Species 0.000 description 2
- 235000004520 Lindera benzoin Nutrition 0.000 description 2
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000009854 mucosal lesion Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药组合物的制备方法，特别涉及用于治疗胃炎的中药组合物的制备方法以及用该方法制备的药物制剂。通过本发明的方法制备的产品具有稳定性好、治疗效果显著等特点。本发明所述中药组合物，由以下方法制备得到：百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成80‑200目粉末；剩余药味加水煎煮2‑4次，每次0.5‑3小时，合并药液滤过浓缩至相对密度1.10‑1.50的浸膏；粉末与浸膏混合得到药物活性物质，经过制剂方法，制备成药物制剂组合物。
Description
发明领域
本发明涉及一种中药组合物的制备方法，特别涉及用于治疗胃炎的中药组合物的制备方法以及用该方法制备的药物制剂。
背景技术
摩罗丹是一种和胃降逆，健脾消胀，通络定痛的药物。用于慢性萎缩性胃炎及胃疼，胀满，痞闷，纳呆，嗳气，烧心等症。用法用量，口服，蜜丸一次9～18g，一日3次，饭前用米汤或温开水送下，或遵医嘱。其由百合、麦冬、石斛、茯苓、白术(麸炒)、乌药、白芍、三七、延胡索(醋炙)、鸡内金(炒香)、玄参、当归等18味中药制备而成，药理作用如下
1作用：当归对痢疾杆菌、霍乱弧菌、变形杆菌、大肠杆菌均有抑制作用，三七总皂甙对某些真菌有较强抑制作用。
2胃粘膜：本方对胃粘膜损伤有修复作用。
3理研究乌药对胃肠道平滑肌有兴奋和抑制的双向调节作用，促进消化液分泌；鸡内金提高胃液分泌量，酸度和消化能力。
4免疫功能：据药理性实验茯苓、白术除健脾外，有效提高体液免疫功能。
5药理发现本方中三七、当归、茯苓等皆有护肝、解除酒精肝中毒，促进肝中血清转化的功能。
中国专利公开了摩罗丹制剂的以下配方
所述白术用麸炒，延胡索用醋炙，鸡内金选用炒鸡内金。
以及制备方法：
以上十八味，加水煎煮1-3次，每次1.5-3小时，合并煎液，滤过，滤液浓缩至适量，加入乙醇，使含醇量达60-80％，静置，滤过，回收乙醇，滤液浓缩，加水冷藏，滤过，最后经过常规工序直接或加入药学上可接受的赋型剂制成临床可接受的剂型。
中国专利200710120838.4公开了摩罗丹以下含量测定方法，
含量测定如下：
照高效液相色谱法测定；
色谱条件与系统适应性试验：用十八烷基硅烷键合硅胶为填充剂；以15-60:40-85的乙腈-水为流动相；检测波长为230nm，理论板数按芍药苷峰计算应不低于1000～5000；
对照品溶液的制备：精密称取芍药苷对照品适量，加溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯制成每1ml含30-50μg的溶液，即得；
供试品溶液的制备：取摩罗丹小蜜丸或重量差异项下的大蜜丸，剪碎，精密称取1～10g，加入硅藻土1～10g，研匀，置具塞锥形瓶中，精密加入溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯15-25ml，密塞，称重，超声处理或热回流或冷浸提取30分钟，取出放至室温后称重，用溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯补足至15-25ml摇匀，滤过，精密吸取续滤液4-6ml，置10ml量瓶中，加溶剂甲醇、乙醇、正丁醇、水、三氯甲烷或乙酸乙酯稀释至刻度，摇匀，即得；
测定法：分别精密吸取对照品溶液与供试品溶液各20μl，注入液相色谱仪，测定，即得；摩罗丹每1g含白芍以芍药苷C23H28O11计，不得少于0.8mg。
本发明人在临床和生产实践中发现，现有技术在疗效，稳定性，原料的节约等方面需要改进，以提高药物的作用，延长储存期，减少药物的使用量，提高药物的适应性，为此本发明人对现有技术进行了改进，从而完成了本发明。
发明内容：
为改进现有技术的缺陷，本发明提供一种摩罗丹的新的制备方法，本发明所述方法，其配方如下：
其制备方法如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成80-200目粉末；剩余药味加水煎煮2-4次，每次0.5-3小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，经过制剂方法，制备成药物制剂组合物。
优选的，本发明的制备方法如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成100目粉末；剩余药味加水煎煮3次，每次2小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，经过制剂方法，制备成药物制剂组合物。
本发明优选的制剂为浓缩丸，其制备方法如下，取粉末与浸膏混合的药物活性成分、粉碎后药粉每1重量份加0.6-1.5重量份炼蜜制成浓缩蜜丸。
本发明的方法和现有技术相比，主要活性成分明显增加，药效明显提高，制剂稳定性明显提高，
以下通过实验数据说明本发明的有益效果：
实验内容：
本发明和现有技术进行对比实验
实验1、对酸性乙醇致大鼠急性胃黏膜损伤的影响
动物分组给药，于给药第7天各组动物分别禁食不禁水48h，试验前各组动物再灌胃给药(水)1次，2h后每只大鼠灌胃酸性乙醇2ml(150mmol/L盐酸与60％乙醇按1∶1比例混合)，1h后分别用过量乙醚麻醉大鼠致死，开腹取胃，用夹子夹紧贲门，由幽门注入1％甲醛溶液5ml，夹紧幽门，将全胃置于1％甲醛溶液中固定10min，沿胃大弯剪开，将胃外翻，用清水轻轻洗去内容物，将胃平铺于玻璃板上，用精密卡尺测量胃黏膜损伤长度，以损伤长度(损伤宽度大于1mm者加倍计算)总和作为胃黏膜损伤指数，并计算抑制率。
实验结果如下：
从结果可见，各组大鼠胃黏膜均有不同程度损伤，本发明组和现有技术组均较模型对照组轻，损伤指数明显降低(P<0.05)。
大鼠再生粘膜厚度的比较
| 组别 | 动物数(只) | 再生粘膜厚度(μm) |
| 对照组 | 10 | 420 |
| 模型组 | 10 | 100 |
| 本发明组 | 10 | 345 |
| 现有技术组 | 10 | 300 |
溃疡灶肉芽瘢痕层厚度的比较
| 组别 | 动物数(只) | 肉芽瘢痕层厚度(μm) |
| 对照组 | 10 | 0 |
| 模型组 | 10 | 0.6 |
| 本发明组 | 10 | 0.16 |
| 现有技术组 | 10 | 0.24 |
实验2、对大鼠胃液分泌的影响
动物分组给药，每组10只大鼠，末次给药后各组动物分别禁食禁水24h，用乙醚麻醉，沿腹中线剪开小口，轻轻拉出胃，结扎幽门，再由十二指肠给药1次，缝合腹壁切口，6h后拆线开腹结扎贲门，摘除全胃，用滤纸擦净血迹，沿胃大弯剪开胃壁，倾出胃内容物，收集于刻度离心管中，以1500r/min速度离心10min，精确记录胃液量，以酚红为指示剂测定胃液总酸度，采用麦特毛细管法测定胃蛋白酶活性。
实验结果如下：
从结果可见，本发明组和现有技术组均可降低胃液总酸度及胃蛋白酶活性。
实验3、体内抗菌试验：
本发明组和现有技术组均可以减少金黄色葡萄球菌感染小鼠死亡数,延长感染小鼠的存活天数；
实验结果如下：
实验4.抗炎试验结果：
本发明组和现有技术组均可降低二甲苯所致小鼠耳廓肿胀度。
对小鼠迟发型变态反应(足跖增厚法)影响(足跖厚度差值mm)
| 剂量组 | 动物数(只) | 注射后24h足跖肿胀度(mm) |
| 阴性对照组 | 10 | 0.215 |
| 本发明组 | 10 | 0.465 |
| 现有技术组 | 10 | 0.346 |
实验5、加速稳定性实验
将样品放置在40℃±2℃、相对湿度75％±5％的条件下放置于恒温恒湿箱中，以设定时间取样，对有关成分进行含量测定，试验后的初步稳定性试验结果如下
本发明样品试验后的初步稳定性试验结果
现有技术样品试验后的初步稳定性试验结果
本发明的优点主要表现在：
通过改进制备方法，取得了以下技术效果：降低了药物的服用量，活性成分的含量有所提高，制剂稳定性有所提高，药物的疗效有所提高。
具体实施方式：
以下通过实施例进一步说明本发明，但不作为对本发明的限制。
实施例1
其制备方法如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成100目粉末；剩余药味加水煎煮3次，每次2小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，制丸、干燥制成浓缩丸；或粉末与浸膏混合、制粒、干燥制成胶囊剂或片剂；
实施例2
其制备方法如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成80-200目粉末；剩余药味加水煎煮2次，每次0.5小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，制丸、干燥制成浓缩丸；或粉末与浸膏混合、制粒、干燥制成胶囊剂或片剂；
实施例3
其制备方法如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成80-200目粉末；剩余药味加水煎煮4次，每次3小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合、制丸、干燥制成浓缩丸；粉末与浸膏混合得到药物活性物质，制丸、干燥制成浓缩丸；或粉末与浸膏混合、制粒、干燥制成胶囊剂或片剂；
以上实施例方法制备的样品，经过含量测定法测定：每1g含白芍以芍药苷C23H28O11计，不少于1.4mg。
Claims (6)
1.一种治疗胃炎的中药组合物的制备方法，所述中药组合物由以下重量配比的中药原料药制备而成，
其特征在于，所述制备方法步骤如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成80-200目粉末；剩余药味加水煎煮2-4次，每次0.5-3小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，经过制剂方法，制备成药物制剂组合物。
2.根据权利要求1所述的制备方法，其特征在于，所述中药组合物由以下重量配比的中药原料药制备而成，
其特征在于，所述制备方法步骤如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成100目粉末；剩余药味加水煎煮3次，每次2小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，经过制剂方法，制备成药物制剂组合物。
3.根据权利要求1所述的制备方法，其特征在于，所述中药组合物由以下重量配比的中药原料药制备而成，
其特征在于，所述制备方法步骤如下：
百合、三七、鸡内金、蒲黄、延胡索、九节菖蒲六味药粉碎成100目粉末；剩余药味加水煎煮3次，每次2小时，合并药液滤过浓缩至相对密度1.10-1.50的浸膏；粉末与浸膏混合得到药物活性物质，制丸、干燥制成浓缩丸；或粉末与浸膏混合、制粒、干燥制成胶囊剂或片剂。
4.根据权利要求1所述的制备方法，其特征在于，所述中药组合物为浓缩丸。
5.根据权利要求1所述的制备方法，其特征在于，所述中药组合物为胶囊剂。
6.根据权利要求1所述的制备方法，其特征在于，所述中药组合物为片剂。
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510939828.8A CN105477361B (zh) | 2015-12-16 | 2015-12-16 | 一种治疗胃炎的中药组合物制备方法及制剂 |
| PCT/CN2016/073419 WO2017101210A1 (zh) | 2015-12-16 | 2016-02-04 | 一种治疗胃炎的中药组合物制备方法及制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510939828.8A CN105477361B (zh) | 2015-12-16 | 2015-12-16 | 一种治疗胃炎的中药组合物制备方法及制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105477361A CN105477361A (zh) | 2016-04-13 |
| CN105477361B true CN105477361B (zh) | 2019-06-28 |
Family
ID=55664872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510939828.8A Active CN105477361B (zh) | 2015-12-16 | 2015-12-16 | 一种治疗胃炎的中药组合物制备方法及制剂 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN105477361B (zh) |
| WO (1) | WO2017101210A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113262217A (zh) * | 2021-02-24 | 2021-08-17 | 邯郸制药股份有限公司 | 一种保护胃黏膜的物质及其制剂与应用 |
| CN115990203B (zh) * | 2021-10-18 | 2023-12-26 | 林玉枝 | 一种含有木油桐叶片成分的防治慢性萎缩性胃炎的制剂及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840091A (zh) * | 2005-04-02 | 2006-10-04 | 周宇 | 一种治疗萎缩性胃炎新型中药及制法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114431C (zh) * | 2000-09-11 | 2003-07-16 | 李恩复 | 一种治疗萎缩性胃炎的药剂及制备方法 |
| CN1239187C (zh) * | 2003-04-17 | 2006-02-01 | 邯郸制药有限公司 | 治疗胃炎的药物组合物、制备方法、用途和质量控制方法 |
-
2015
- 2015-12-16 CN CN201510939828.8A patent/CN105477361B/zh active Active
-
2016
- 2016-02-04 WO PCT/CN2016/073419 patent/WO2017101210A1/zh active Application Filing
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1840091A (zh) * | 2005-04-02 | 2006-10-04 | 周宇 | 一种治疗萎缩性胃炎新型中药及制法 |
Non-Patent Citations (1)
| Title |
|---|
| 正交试验法优选摩罗片的提取工艺;高立霞 等;《泰山医学院学报》;20090125;第30卷(第1期);第32-34页 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017101210A1 (zh) | 2017-06-22 |
| CN105477361A (zh) | 2016-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512482A (zh) | 一种鬼箭羽提取物及其降糖活性与在制备降血糖制品中的应用 | |
| CN101199831A (zh) | 治疗胃脘痛的中药胶囊剂及制法和质量控制方法 | |
| CN105477361B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN1709341B (zh) | 一种益气健脾的药物组合物及其制备方法和用途 | |
| CN105477359B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN102058822B (zh) | 一种用于健胃消食的药物组合物 | |
| CN105535533A (zh) | 一种治疗胃炎的中药组合物 | |
| CN105477360B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN109248188A (zh) | 一种金雀根提取物的制备方法及其应用 | |
| CN105477364B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105327149B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105381259B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105395889B (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN101869675B (zh) | 一种治疗暑湿感冒的中药组合物颗粒剂及其制备方法 | |
| CN105456738A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105477362A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105497557A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105267564A (zh) | 萆薢总皂苷在制备防治糖尿病肾病药物中的应用 | |
| CN100408055C (zh) | 一种治疗伤科疾病的中药组合物及其制备方法和质量控制方法 | |
| CN105477358A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105381257A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105456737A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| CN105477363A (zh) | 一种治疗胃炎的中药组合物制备方法及制剂 | |
| WO2014090122A1 (zh) | 一种用于降糖的药物组合物及其制备方法和用途 | |
| CN113288962B (zh) | 一种用于治疗非哺乳期乳腺炎的中药制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method and preparation of traditional Chinese medicine composition for treating gastritis Effective date of registration: 20220225 Granted publication date: 20190628 Pledgee: China Construction Bank Corporation Handan Fudong sub branch Pledgor: HANDAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022130000009 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20190628 Pledgee: China Construction Bank Corporation Handan Fudong sub branch Pledgor: HANDAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2022130000009 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method and preparation of a traditional Chinese medicine combination for treating gastritis Granted publication date: 20190628 Pledgee: China Construction Bank Corporation Handan Fudong sub branch Pledgor: HANDAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980006897 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |